CD274 and melanoma: ARG-1, ROS, PD-L1, and NO, known mediators of MDSC immunosuppressive effects [157,158,159,160,161], were expressed in CCR5+ MDSCs at higher levels compared with their CCR5− counterparts and were linked to melanoma progression [156].